This page shows all past and ongoing consultations towards EPF has committed to submit a response jointly with its members. You can access the draft responses and add your comments by clicking on the appropriate link. This page is restricted to Members only.



Blood, tissues and cells for medical treatments & therapies – revised EU rules 

EU legislation provides high safety and quality standards for blood, tissues and cells used for medical treatments and therapies. This initiative will update the EU rules on scientific and technological developments in this field, including innovative therapies. It will also address the (re)emergence of communicable diseases, including lessons learnt from the COVID-19 pandemic, and the increasing commercialisation and globalisation of this sector, so contributing to the European Health Union. 

More information  

Deadline: 15 April 2021




European Health Data Space 

Health is an area where Europe can undoubtedly benefit from the data revolution. Proper use of health data can improve health systems’ sustainability, foster disease prevention, increase the quality, safety and patient centredness of healthcare, decrease costs and transform care into a more participatory process. Nevertheless, the road to fully exploit the potential benefits of data in health is only partially built, still extremely fragmented and undeveloped with and for patients. In its response to this public consultation, EPF called for the creation of a patient-centred European Health Data Space.   

EPF Response to the Roadmap  

Public consultation: input form opens in the second quarter of 2021. 


 3rd health programme (2014-2020) – final evaluation 

The final evaluation of the 3rd health programme that ran from 2014 to 2020 will assess: - its results and the impact of those results, - its effectiveness, cost-efficiency and EU-added value, - what worked well and what did not. The lessons learnt from the evaluation will be used to improve the implementation of the 4th health programme that will run from 2021 to 2027.  

More information 

Public consultation: input form opens in the second quarter of 2021. 


Evaluation of the cross-border healthcare directive  

EPF has worked extensively on the Cross-border healthcare Directive (2011/24/EU). Building on our previous work in this topic, we have engaged on the recent public consultation on the evaluation of this Directive by the European Commission. Our response has identified the following priorities: 1) patient’s rights, 2) information for patients, 3) equity of access, and 4) patient’s involvement in assessing the Directive.  

More information 

EPF Response to the Roadmap 

Public consultation: input form opens in the second quarter of 2021. 


A European approach for trustworthy artificial intelligence 

In its Communication “Artificial Intelligence for Europe”, the Commission announced the drafting of ethics guidelines in the field, by an independent Expert Group representing various stakeholders. The group has published draft guidelines in December 2018 and, following stakeholder consultations, is revising the document. The Communication will present how the Commission will take this work forward, including key requirements for trustworthy Artificial Intelligence, and outline next steps.  

More information 

Roadmapinput form open date to be confirmed.  


Read our past consultations